| Disease ID | Disease name | Reference |
|---|
| MESH:D000077192 |
Adenocarcinoma of Lung |
PMID:11079726 |
| MESH:D000138 |
Acidosis |
PMID:3769383; PMID:6506685 |
| MESH:D001018 |
Aortic Diseases |
PMID:2251542 |
| MESH:D001145 |
Arrhythmias, Cardiac |
PMID:10326941; PMID:18724532; PMID:2222089; PMID:2438095; PMID:3330186; PMID:6506685; PMID:7826681 |
| MESH:D001167 |
Arteritis |
PMID:12180796; PMID:8572928; PMID:9879811 |
| MESH:D001851 |
Bone Diseases, Metabolic |
PMID:26851681 |
| MESH:D001862 |
Bone Resorption |
PMID:26851681 |
| MESH:D001927 |
Brain Diseases |
PMID:8517990 |
| MESH:D001930 |
Brain Injuries |
PMID:10565195 |
| MESH:D002318 |
Cardiovascular Diseases |
PMID:1835291 |
| MESH:D002543 |
Cerebral Hemorrhage |
PMID:3949080 |
| MESH:D002653 |
Child Behavior Disorders |
PMID:1758745 |
| MESH:D002819 |
Chorea |
PMID:1424400 |
| MESH:D003128 |
Coma |
PMID:6858124 |
| MESH:D003221 |
Confusion |
PMID:3769383; PMID:637435; PMID:6625253 |
| MESH:D003693 |
Delirium |
PMID:6506685 |
| MESH:D003866 |
Depressive Disorder |
PMID:7437783 |
| MESH:D004310 |
Double Outlet Right Ventricle |
PMID:2251542 |
| MESH:D004409 |
Dyskinesia, Drug-Induced |
PMID:6625253 |
| MESH:D004487 |
Edema |
PMID:22982570 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
PMID:2360338; PMID:823660 |
| MESH:D005221 |
Fatigue |
PMID:3769383 |
| MESH:D005334 |
Fever |
PMID:20940509 |
| MESH:D005767 |
Gastrointestinal Diseases |
PMID:1835291; PMID:7826681; PMID:9164358 |
| MESH:D006029 |
Glycosuria |
PMID:718247 |
| MESH:D006212 |
Hallucinations |
PMID:17516267 |
| MESH:D006261 |
Headache |
PMID:6386511; PMID:6838301 |
| MESH:D006319 |
Hearing Loss, Sensorineural |
PMID:3627078 |
| MESH:D006330 |
Heart Defects, Congenital |
PMID:2251542 |
| MESH:D006470 |
Hemorrhage |
PMID:22982570 |
| MESH:D006930 |
Hyperalgesia |
PMID:7908645 |
| MESH:D006943 |
Hyperglycemia |
PMID:1445173; PMID:6506685; PMID:718247 |
| MESH:D006948 |
Hyperkinesis |
PMID:15351080 |
| MESH:D006973 |
Hypertension |
PMID:10230855 |
| MESH:D006984 |
Hypertrophy |
PMID:16651698 |
| MESH:D007008 |
Hypokalemia |
PMID:18724532; PMID:2596942; PMID:2973024; PMID:3330186; PMID:3408637; PMID:3662713; PMID:3707814; PMID:3940495; PMID:6506685; PMID:8177851 |
| MESH:D007010 |
Hyponatremia |
PMID:12086552; PMID:8177851 |
| MESH:D007022 |
Hypotension |
PMID:3994078; PMID:6506685 |
| MESH:D007174 |
Disruptive, Impulse Control, and Conduct Disorders |
PMID:6093179 |
| MESH:D007177 |
Inappropriate ADH Syndrome |
PMID:12086552 |
| MESH:D007235 |
Infant, Premature, Diseases |
PMID:11605782; PMID:660340 |
| MESH:D007248 |
Infertility, Male |
PMID:16988215 |
| MESH:D007674 |
Kidney Diseases |
PMID:12745095 |
| MESH:D007859 |
Learning Disabilities |
PMID:15351080 |
| MESH:D007964 |
Leukocytosis |
PMID:20940509 |
| MESH:D008569 |
Memory Disorders |
PMID:15351080 |
| MESH:D008659 |
Metabolic Diseases |
PMID:15012710 |
| MESH:D009127 |
Muscle Rigidity |
PMID:8865732 |
| MESH:D009212 |
Myoglobinuria |
PMID:8865732 |
| MESH:D009325 |
Nausea |
PMID:16868215; PMID:2218006; PMID:3074291; PMID:3537092; PMID:6506685 |
| MESH:D009422 |
Nervous System Diseases |
PMID:2038423; PMID:3949080 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
PMID:2251542 |
| MESH:D011595 |
Psychomotor Agitation |
PMID:6288396 |
| MESH:D012206 |
Rhabdomyolysis |
PMID:10441997; PMID:2858780; PMID:7826681 |
| MESH:D012640 |
Seizures |
PMID:10211593; PMID:10230855; PMID:10326941; PMID:10401785; PMID:10819670; PMID:10874349; PMID:10916367; PMID:11734184; PMID:1312320; PMID:1438500; PMID:16715938; PMID:1676814; PMID:17072109; PMID:17671412; PMID:17784538; PMID:18279214; PMID:18326306; PMID:18520175; PMID:1866026; PMID:1901667; PMID:19589454; PMID:2079649; PMID:2087497; PMID:20940509; PMID:2222089; PMID:237450; PMID:2600817; PMID:2623258; PMID:2786601; PMID:2965587; PMID:2969553; PMID:3177989; PMID:3188359; PMID:3225766; PMID:3494838; PMID:3626650; PMID:3723646; PMID:3922683; PMID:3994071; PMID:637435; PMID:6646925; PMID:6858124; PMID:7148765; PMID:7270562; PMID:7824546; PMID:8007033; PMID:8046614; PMID:8048709; PMID:8179767; PMID:8192750; PMID:8346082; PMID:8437130; PMID:8540225; PMID:8799489; PMID:9294318; PMID:9339868; PMID:9717943 |
| MESH:D012893 |
Sleep Wake Disorders |
PMID:1776216; PMID:2520495 |
| MESH:D013036 |
Spasms, Infantile |
PMID:7756814 |
| MESH:D013226 |
Status Epilepticus |
PMID:108053; PMID:11605782; PMID:1541177; PMID:18634420; PMID:19911151; PMID:2038423; PMID:637435 |
| MESH:D013342 |
Stuttering |
PMID:7312482; PMID:7882883; PMID:9756159 |
| MESH:D013375 |
Substance Withdrawal Syndrome |
PMID:7055114 |
| MESH:D013610 |
Tachycardia |
PMID:10230855; PMID:11408986; PMID:16868215; PMID:2623258; PMID:2856947; PMID:3408637; PMID:4014092; PMID:6625253; PMID:6751238; PMID:7270562; PMID:8346082; PMID:8888546 |
| MESH:D013614 |
Tachycardia, Paroxysmal |
PMID:660340 |
| MESH:D013616 |
Tachycardia, Sinus |
PMID:11483122; PMID:7826681 |
| MESH:D013617 |
Tachycardia, Supraventricular |
PMID:660340 |
| MESH:D014188 |
Transposition of Great Vessels |
PMID:2251542 |
| MESH:D014202 |
Tremor |
PMID:1424400; PMID:3074291; PMID:6288396; PMID:6313028; PMID:6506685; PMID:6586482; PMID:7140872; PMID:8017343 |
| MESH:D014549 |
Urinary Incontinence |
PMID:3769383 |
| MESH:D014839 |
Vomiting |
PMID:16868215; PMID:2218006; PMID:3074291; PMID:6625253; PMID:8346082; PMID:8888546 |
| MESH:D016055 |
Urinary Retention |
PMID:6187071; PMID:7235434; PMID:7469216 |
| MESH:D017674 |
Hypophosphatemia |
PMID:6506685 |
| MESH:D018476 |
Hypokinesia |
PMID:11734184 |
| MESH:D019964 |
Mood Disorders |
PMID:3537092 |
| MESH:D019970 |
Cocaine-Related Disorders |
PMID:11927167 |
| MESH:D051437 |
Renal Insufficiency |
PMID:3494838 |
| MESH:D053565 |
Hypercalciuria |
PMID:8407166 |
| MESH:D053609 |
Lethargy |
PMID:3769383 |
| MESH:D058186 |
Acute Kidney Injury |
PMID:10441997; PMID:2858780 |
| MESH:D062787 |
Drug Overdose |
PMID:10326941; PMID:10565195; PMID:108053; PMID:11605782 |
| MESH:D064420 |
Drug-Related Side Effects and Adverse Reactions |
PMID:2189301; PMID:3792059; PMID:6121526; PMID:7270562 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.